Dr. Mark Christopher Genovese M.D.
Rheumatologist | Rheumatology
1000 Welch Rd 203 Palo Alto CA, 94304About
Dr. Mark Genovese is a rheumatologist practicing in Palo Alto, CA. Dr. Genovese specializes in the treatment of musculoskeletal diseases and systematic autoimmune conditions that can affect the bones, muscles or bones. Eventually, if not treated, these illnesses can also impact the skin, eyes, nervous system and internal organs. Dr. Genovese treats diseases similar to orthopedists but does not perform surgery. Often times, research is conducted to find potential alternatives for the patients illness.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues.
- CCR7 expression and memory T cell diversity in humans.
- Current management of rheumatoid arthritis.
- Treatment of rheumatoid arthritis with total lymphoid irradiation: long-term survival.
- Rules of chemokine receptor association with T cell polarization in vivo.
- Central nervous system lupus and pregnancy: 11-year experience at a single center.
- Rheumatic syndromes associated with malignancy.
- The Early Rheumatoid Arthritis (ERA) trial comparing the efficacy and safety of etanercept and methotrexate.
- Unlocking the "PAD" lock on rheumatoid arthritis.
- Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
- Associations between rheumatoid arthritis and malignancy.
- Demyelination and inhibition of tumor necrosis factor (TNF).
- Temporal effects of a COX-2-selective NSAID on bone ingrowth.
- Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus.
- Antigen microarray profiling of autoantibodies in rheumatoid arthritis.
Clinical Trials
- Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) Who Previously Completed 24 Weeks of Blinded Treatment in One of the Core Studies - CREDO 1, 2 or 3.
- Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Disease
Publications
- RHEUMATOLOGYNovel small molecule therapeutics in rheumatoid arthritis2013
- JOURL OF RHEUMATOLOGYLongterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis2013
- Anls of the rheumatic diseasesEfficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding2013
- JOURL OF RHEUMATOLOGYEfficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized2013
- JOURL OF RHEUMATOLOGYEffects of Fostamatinib (R788), an Oral Spleen Tyrosine Kise Inhibitor2013
- ARTHRITIS AND RHEUMATISMTabalumab in Rheumatoid Arthritis Patients With an Idequate Response to Methotrexate2013
- JOURL OF ORTHOPAEDIC RESEARCHEffects of sclerostin antibody on healing of a non-critical size femoral bone defect2013
- JOURL OF RHEUMATOLOGYLongterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid2012
- JOURL OF RHEUMATOLOGYEffect of Golimumab on Patient-reported Outcomes in Rheumatoid Arthritis2012
- Anls of the rheumatic diseasesTabalumab, an anti-BAFF monoclol antibody0
- ARTHRITIS AND RHEUMATISMSubcutaneous Abatacept Versus Intravenous Abatacept A Phase IIIb Noninferiority Study2011
- ARTHRITIS AND RHEUMATISMAtacicept in Patients With Rheumatoid Arthritis2011
- JOURL OF RHEUMATOLOGYA 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of2011
- ARTHRITIS AND RHEUMATISMAn Oral Syk Kise Inhibitor in the Treatment of Rheumatoid Arthritis A Three-Month Randomized2011
- ARTHRITIS AND RHEUMATISMLY2439821, a Humanized Anti-Interleukin-17 Monoclol Antibody2010
- ANLS OF THE RHEUMATIC DISEASESSafety of biological therapies following rituximab treatment in rheumatoid arthritis patients2009
- JOURL OF RHEUMATOLOGYFirst Report of Idiopathic Granulomatous Mastitis Treated with Methotrexate Monotherapy2009
- JOURL OF RHEUMATOLOGYLess Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy2009
- JOURL OF BIOMEDICAL MATERIALS RESEARCH PART AEfficacy of a p38 mitogen activated protein kise inhibitor2009
- ARTHRITIS AND RHEUMATISMInhibition of p38: Has the Fat Lady Sung2009
- ARTHRITIS RESEARCH & THERAPYBlood autoantibody and cytokine profiles predict response to anti2009
- ARTHRITIS AND RHEUMATISMInterleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis2008
- ARTHRITIS AND RHEUMATISMOcrelizumab, a humanized anti-CD20 monoclol antibody2008
- ANLS OF THE RHEUMATIC DISEASESEfficacy and safety of the selective co2008
- CLINICAL AND EXPERIMENTAL RHEUMATOLOGYEfficacy results from pivotal clinical trials with abatacept2007
- ARCHIVES OF DERMATOLOGYA pilot trial of rituximab in the treatment of patients with dermatomyositis2007
- ANLS OF THE RHEUMATIC DISEASESProteomic alysis of secreted proteins in early rheumatoid arthritis2007
- JOURL OF RHEUMATOLOGYA pilot study of tumor necrosis factor inhibition in erosive2007
- JOURL OF RHEUMATOLOGYSafety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed2007
- JOURL OF CLINICAL INVESTIGATIONSelective tyrosine kise inhibition by imatinib mesylate for the treatment of autoimmune arthritis2006
- JOURL OF RHEUMATOLOGYA randomized, blinded2005
- Current rheumatology reportsMagement of co-morbidities and general medical conditions in patients with rheumatoid arthritis.2005
- NEW ENGLAND JOURL OF MEDICINEAbatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition2005
- ARTHRITIS AND RHEUMATISMAntigen microarray profiling of autoantibodies in rheumatoid arthritis2005
- JOURL OF RHEUMATOLOGYLongterm safety, efficacy2005
- AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGYFactors that predict prematurity2005
- JCR-JOURL OF CLINICAL RHEUMATOLOGYBiologic therapies in clinical development for the treatment of rheumatoid arthritis2005
- JOURL OF BIOMEDICAL MATERIALS RESEARCH PART ATemporal effects of a COX-2-selective NSAID on bone ingrowth2005
- CLINICAL ORTHOPAEDICS AND RELATED RESEARCHPharmacologic modulation of periprosthetic osteolysis2005
- RHEUMATIC DISEASE CLINICS OF NORTH AMERICAAssociations between rheumatoid arthritis and maligncy2004
- ARTHRITIS AND RHEUMATISMCombition therapy with etanercept2004
- RHEUMATIC DISEASE CLINICS OF NORTH AMERICATreatment of rheumatoid arthritis with etanercept2004
- ANLS OF THE RHEUMATIC DISEASESUnlocking the PAD lock on rheumatoid arthritis2004
- Arthritis research & therapyA randomized, controlled trial of interferon-beta2004
- JOURL OF RHEUMATOLOGYInterleukin 1 receptor antagonist inhibits localized bone formation in vivo2003
- INTERTIOL JOURL OF IMMUNOPATHOLOGY AND PHARMACOLOGYCOX-2 selective inhibitors and bone2003
- JOURL OF MAGNETIC RESONCE IMAGINGImaging of the articular cartilage in osteoarthritis of the knee joint2003
- JOURL OF BIOMEDICAL MATERIALS RESEARCH PART AModulation of bone ingrowth2003
- CURRENT OPINION IN RHEUMATOLOGYRheumatic syndromes associated with maligncy2003
- JOURL OF ORTHOPAEDIC RESEARCHCOX-2 selective NSAID decreases bone ingrowth in vivo2002
- jourl of materl-fetal & neotal medicineCentral nervous system lupus and pregncy: 11-year experience at a single center.2002
- ARTHRITIS AND RHEUMATISMEtanercept versus methotrexate in patients with early rheumatoid arthritis - Two2002
- ARTHRITIS AND RHEUMATISMLong-term followup of patients treated with total lymphoid irradiation for lupus nephritis2002
- TURE MEDICINEAutoantigen microarrays for multiplex characterization of autoantibody responses2002
- AMERICAN JOURL OF PATHOLOGYExpression of the chemokine receptors CCR4, CCR52002
- JOURL OF CLINICAL INVESTIGATIONRules of chemokine receptor association with T cell polarization in vivo2001
- ARTHRITIS AND RHEUMATISMDemyeliting and neurologic events reported in association with tumor necrosis factor alpha2001
- ARTHRITIS AND RHEUMATISMTreatment of rheumatoid arthritis with total lymphoid irradiation - Long-term survival2001
- JOURL OF CLINICAL INVESTIGATIONBonzo/CXCR6 expression defines type 12001
- HOSPITAL PRACTICECurrent magement of rheumatoid arthritis2001
- JOURL OF IMMUNOLOGYCutting edge: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal2000
- JOURL OF EXPERIMENTAL MEDICINELymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine2000
- POSTGRADUATE MEDICINEJoint and soft-tissue injection - A useful adjuvant to systemic and local treatment1998
- WESTERN JOURL OF MEDICINEFever, rash, and arthritis in a woman with silicone gel breast implants1997
- SOUTHERN MEDICAL JOURLLemierre's syndrome1997
Dr. Mark Christopher Genovese M.D.'s Practice location
Dr. Mark Christopher Genovese M.D.'s reviews
Write ReviewPatient Experience with Dr. Genovese
Recommended Articles
- CNN Producer Lauren Lee on Battling Lupus: A Fight to Regain Oneself
As a girl, Lauren Lee lived the life of her dreams. She was a Junior at Kent State University who was able to do what she loved: Journalism. She was at the top of her classes and seemed to have it all, that is until September 2001 when she suffered from an unexplainable condition. She was confused,...
- Round and Yellow M 66 Pill
M 66 PillThis pill is round and yellow in color with an imprint of “M 66”. It has been identified as meloxicam 7.5 mg, which is used for the treatment of inflammatory conditions, fibromyalgia, osteoarthritis, rheumatoid arthritis, and tendonitis.Under the Controlled Substances Act, meloxicam is...
- 8 Supplements for Arthritis Pain
Arthritis is a painful condition that usually affects the joints. Around 350 million people in the world have arthritis. According to the Centers for Disease Control and Prevention (CDC), there are approximately more than 50 million people with arthritis symptoms in the US alone. Supplements for...
- Understanding Peripheral Neuropathy in Adult Lupus Patients
Systemic Lupus Erythematosus (SLE) is an autoimmune disease that has been affecting millions of people, both young and old worldwide. Numerous studies about this disease have been conducted by different academic, pharmaceutical, and medical organizations. Over the course of continuous and extensive...
- Nonsteroidal Anti-Inflammatory Drugs for Rheumatoid Arthritis
What is rheumatoid arthritis?Rheumatoid arthritis is a chronic inflammatory disorder, which happens to affect more than just the joints. In a few cases of this medical condition, other parts of the body such as the skin, heart, lungs, blood vessels, and eyes are also affected.It is also considered...
- Why Is Chemotherapy Used for Lupus?
What is Lupus?Systemic lupus erythematosus, also known as lupus, is a disease of the immune system. The immune system protects the body from infection. In lupus, however, the immune system turns against the body, leading to tissue damage and illness. Thus, lupus is called an autoimmune disease.Men...
Nearby Providers
- Dr. Neelakshi Patel M.D.1835 PARK AVE SAN JOSE CA 95126
- Dr. Amy B. Elliot MD1300 Crane Street Menlo Park California 94025
- Dr. Claudia S Kuzis MD701 E El Camino Real Mountain View CA 94040
- Dr. Eliza Farmer Chakravarty MD1000 Welch Rd Palo Alto CA 94304
- Dr. Ernesto Zatarain-rios MD1501 Trousdale Dr Burlingame CA 94010
- Dr. Michael Popkin Stevens M.D.101 S San Mateo Dr San Mateo CA 94401